EVENTIDE ASSET MANAGEMENT, LLC
Q4 2021 13F-HR Holdings
Net value change ($000)
+242,288
(3.2%)
New positions
14
Sold out positions
20
Turnover %
10.1%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q3 2021
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| DLO | 129,100 | 468.5% |
| GLBE | 101,312 | 295.1% |
| GH | 66,376 | 298.3% |
| KnowBe4, Inc. | 66,205 | NEW |
| Prometheus Biosciences, Inc. | 59,981 | 70.5% |
| ARGX | 43,887 | 43.6% |
| TREX | 43,778 | 48.7% |
| Biohaven Pharmaceutical Holding Co Ltd. | 41,263 | 22.4% |
| MTD | 40,461 | 23.2% |
| TT | 37,632 | 34.1% |
Top Reduces (Value $000, Stocks/ETFs)
| FVRR | -127,321 | -100.0% |
| TWLO | -125,543 | -100.0% |
| Trillium Therapeutics Inc. | -91,793 | -100.0% |
| CRWD | -69,032 | -35.4% |
| Allakos Inc. | -65,816 | -98.7% |
| ZYMEWORKS INC | -62,090 | -57.3% |
| ASND | -43,471 | -15.6% |
| Turning Point Therapeutics, Inc. | -38,397 | -100.0% |
| PLRX | -36,279 | -98.4% |
| FIVN | -33,761 | -14.4% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|